A Bioactive Disintegrable Polymer Nanoparticle for Synergistic Vascular Anticalcification

• Published in: ACS nano Vol. 17; no. 19; pp. 18775 - 18791
• Main Authors: Adelnia, Hossein, Moonshi, Shehzahdi Shebbrin, Wu, Yuao, Bulmer, Andrew C., Mckinnon, Ryan, Fastier-Wooller, Jarred William, Blakey, Idriss, Ta, Hang Thu
• Format: Journal Article
• Language: English
• Published: American Chemical Society 10-10-2023
• Subjects: antioxidant; chronic kidney disease; polysuccinimide; anticalcification; vascular calcification; curcumin
• ISSN: 1936-0851; 1936-086X
• DOI: 10.1021/acsnano.3c03041

Although poly­(aspartic acid) (PASP), a strong calcium chelating agent, may be potentially effective in inhibition of vascular calcification, its direct administration may lead to side effects. In this study, we employed polysuccinimide, a precursor of PASP, to prepare targeted polysuccinimide-based nanoparticles (PSI NPs) that not only acted as a prodrug but also functioned as a carrier of additional therapeutics to provide powerful synergistic vascular anticalcification effect. This paper shows that chemically modified PSI-NPs can serve as effective nanocarriers for loading of hydrophobic drugs, in addition to anticalcification and antireactive oxygen species (anti-ROS) activities. Curcumin (Cur), with high loading efficiency, was encapsulated into the NPs. The NPs were stable for 16 h in physiological conditions and then slowly dissolved/hydrolyzed to release the therapeutic PASP and the encapsulated drug. The drug release profile was found to be in good agreement with the NP dissolution profile such that complete release occurred after 48 h at physiological conditions. However, under acidic conditions, the NPs were stable, and Cur cumulative release reached only 30% after 1 week. Though highly effective in the prevention of calcium deposition, PSI NPs could not prevent the osteogenic trans-differentiation of vascular smooth muscle cells (VSMCs). The presence of Cur addressed this problem. It not only further reduced ROS level in macrophages but also prevented osteogenic differentiation of VSMCs in vitro. The NPs were examined in vivo in a rat model of vascular calcification induced by kidney failure through an adenine diet. The inclusion of Cur and PSI NPs combined the therapeutic effects of both. Cur-loaded NPs significantly reduced calcium deposition in the aorta without adversely affecting bone integrity or noticeable side effects/toxicity as examined by organ histological and serum biochemistry analyses.